Clinical Trial Update: Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nicotine patches to reduce hand-foot syndrome in patients with metastatic breast cancer receiving capecitabine; the study is terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Nicotine patch (nicotine patch)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer, Chemotherapeutic Agent Toxicity | Phase 2 | Status: TERMINATED | Results posted: 2020-10-05